Humira and Sulfanilamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humira (adalimumab) and Sulfanilamide (sulfanilamide). Common drug interactions include drug hypersensitivity among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Humira and Sulfanilamide. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.

What is Sulfanilamide?

Sulfanilamide has active ingredients of sulfanilamide. eHealthMe is studying from 150 Sulfanilamide users. Check the latest studies of Sulfanilamide.

On Jul, 27, 2026

31 people who take Humira and Sulfanilamide together, and have interactions are studied.

Humira and Sulfanilamide drug interactions.

What are the common drug interactions of Humira and Sulfanilamide, by gender? *:

female:

Drug hypersensitivity
Drug ineffective
Injection site inflammation
Abscess (pus)
Dry throat
Ear infection
Injection site pain
Lethargy (tiredness)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Rash

male:

Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Defaecation urgency (a sudden compelling urge to defecate)
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Glaucoma (increased fluid pressure in the eye with vision loss)
Nasopharyngitis (inflammation of the nasopharynx)
Precancerous cells present
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

What are the common drug interactions of Humira and Sulfanilamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Injection site inflammation
Abscess (pus)
Drug hypersensitivity
Dry throat
Ear infection
Injection site pain
Lethargy (tiredness)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Sinusitis (inflammation of sinus)
Asthenia (weakness)

50-59:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Psoriasis (immune-mediated disease that affects the skin)
Asthma
Chronic kidney disease
Depression
Drug ineffective
Drug intolerance (drug sensitivity)
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
Hypertension (high blood pressure)
Migraine (headache)

60+:

Drug hypersensitivity

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 29.03%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 12.90%
Sleep Disorder: 2 people, 6.45%
High Blood Pressure: 2 people, 6.45%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 6.45%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Humira and Sulfanilamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously